Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria.
Autor: | Tietie LE; Oncology and Pathological Studies Unit, Lagos University Teaching Hospital, Lagos 102215, Nigeria., Okunade KS; Oncology and Pathological Studies Unit, Lagos University Teaching Hospital, Lagos 102215, Nigeria.; Department of Obstetrics & Gynaecology, College of Medicine, University of Lagos, PMB 12003, Lagos, Nigeria., SoibI-Harry AP; Department of Obstetrics & Gynaecology, College of Medicine, University of Lagos, PMB 12003, Lagos, Nigeria., John-Olabode SO; Department of Haematology and Blood Transfusion, College of Medicine, University of Lagos, PMB 12003, Lagos, Nigeria., Anorlu RI; Oncology and Pathological Studies Unit, Lagos University Teaching Hospital, Lagos 102215, Nigeria.; Department of Obstetrics & Gynaecology, College of Medicine, University of Lagos, PMB 12003, Lagos, Nigeria. |
---|---|
Jazyk: | angličtina |
Zdroj: | Ecancermedicalscience [Ecancermedicalscience] 2023 Jan 30; Vol. 17, pp. 1501. Date of Electronic Publication: 2023 Jan 30 (Print Publication: 2023). |
DOI: | 10.3332/ecancer.2023.1501 |
Abstrakt: | The link between plasma D-dimer levels and underlying malignancy has been established. How this translates in clinical practice as a marker of detection and prognosis of cervical cancer (CC) is still unknown. This study compared the plasma D-dimer levels in women with and without CC and assessed the associations between plasma D-dimer levels and the stage and grade of CC. It was a comparative cross-sectional study of 65 women with histological diagnosis of CC and an equal number of age-matched cancer-free women enrolled at the University Teaching Hospital in Lagos, Nigeria. Participants' sociodemographic and clinical data as well as venous blood samples for estimation of plasma D-dimer were collected for statistical analyses. A receiver operating characteristic (ROC) analysis is performed to select the cut-off value of plasma D-dimer for differentiating CC from non-cancer. There was a statistically significant difference in the median levels of plasma D-dimer of women with CC and their cancer-free comparison groups (3,120 (1,189-4,515) versus 210 (125-350) ng/mL; p = 0.001). A plasma D-dimer value of 543 ng/mL was chosen in a ROC analysis as the discriminatory cut-off to differentiate CC from non-cancer. There were significant associations between plasma D-dimer levels and the International Federation of Gynaecology and Obstetrics stage ( p = 0.001) or grade ( p = 0.001) of CC. The study, therefore, demonstrated the potential clinical usefulness of plasma D-dimer as a diagnostic and prognostic marker of CC. Competing Interests: The authors declare that they have no competing interests. (© the authors; licensee ecancermedicalscience.) |
Databáze: | MEDLINE |
Externí odkaz: |